Patent details
EP3184523
Title:
N-((4,6-DIMETHYL-2-OXO-L,2-DIHYDROPYRIDIN-3-YL)METHYL)-5-(ETHYL (TETRAHYDRO-2H-PYRAN-4-YL)AMINO)-4-METHYL-4'-(MORPHOLINOMETHYL)-[L,1'-BIPHENYL]-3-CARBOXAMIDE HYDROBROMIDE FOR USE IN THE TREATMENT OF A CELL PROLIFERATIVE DISORDER OF THE HEMATOLOGIC SYSTEM
Basic Information
- Publication number:
- EP3184523
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP161917166
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- N-((4,6-DIMETHYL-2-OXO-L,2-DIHYDROPYRIDIN-3-YL)METHYL)-5-(ETHYL (TETRAHYDRO-2H-PYRAN-4-YL)AMINO)-4-METHYL-4'-(MORPHOLINOMETHYL)-[L,1'-BIPHENYL]-3-CARBOXAMIDE HYDROBROMIDE FOR USE IN THE TREATMENT OF A CELL PROLIFERATIVE DISORDER OF THE HEMATOLOGIC SYSTEM
- French Title of Invention:
- BROMHYDRATE DE N-((4,6-DIMÉTHYL-2-OXO-L,2-DIHYDROPYRIDIN-3-YL)MÉTHYL)-5-(ÉTHYL (TÉTRAHYDRO-2H-PYRAN-4-YL)AMINO)-4-MÉTHYL-4'-(MORPHOLINOMÉTHYL)-[L,1'-BIPHÉNYL]-3-CARBOXAMIDE POUR L'UTILISATION DANS LE TRAITEMENT D'UN TROUBLE DE PROLIFÉRATION CELLULAIRE DU SYSTÈME HÉMATOLOGIQUE
- German Title of Invention:
- N-((4,6-DIMETHYL-2-OXO-L,2-DIHYDROPYRIDIN-3-YL)METHYL)-5-(ETHYL (TETRAHYDRO-2H-PYRAN-4-YL)AMINO)-4-METHYL-4'-(MORPHOLINOMETHYL)-[L,1'-BIPHENYL]-3-CARBOXAMIDE HYDROBROMIDE ZUR VERWENDUNG IN DER BEHANDLUNG EINER ZELLPROLIFERATIVEN KRANKHEIT DES HÄMATOLOGISCHEN SYSTEMS
- SPC Number:
-
Dates
- Filing date:
- 11/04/2013
- Grant date:
- 19/06/2019
- EP Publication Date:
- 28/06/2017
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 19/06/2019
- EP B1 Publication Date:
- 19/06/2019
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 11/04/2033
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 12/06/2019
-
-
- Name:
- Eisai R&D Management Co., Ltd.
- Address:
- 6-10, Koishikawa-4-chome
Bunkyo-ku, Tokyo 112-8088, Japan (JP)
- Name:
- Epizyme Inc
- Address:
- 400 Technology Square, 4th Floor, Cambridge, MA 02139, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 07/08/2019
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- FANG, Frank
- Address:
- United States (US)
2
- Name:
- HUANG, Kuan-chun
- Address:
- United States (US)
3
- Name:
- KUNTZ, Kevin Wayne
- Address:
- United States (US)
4
- Name:
- CHOI, Hyeong Wook
- Address:
- United States (US)
5
- Name:
- MATHIEU, Steven
- Address:
- United States (US)
6
- Name:
- CHANDA, Arani
- Address:
- United States (US)
7
- Name:
- SANDERS, Kristen
- Address:
- United States (US)
Priority
- Priority Number:
- 201261624215 P
- Priority Date:
- 13/04/2012
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 31/5377;
A61P 35/00;
A61P 35/02;
C07D 405/12;
Publication
European Patent Bulletin
1
- Issue number:
- 201925
- Publication date:
- 19/06/2019
- Description:
- Grant (B1)
2
- Issue number:
- 201930
- Publication date:
- 24/07/2019
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 30/04/2026
- Annual Fee Number:
- 14
- Annual Fee Amount:
- 198 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 26/03/2025
- Last Annual Fee Paid Number:
- 13
- Last Annual Fee Paid Amount:
- 180 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM